The American Journal of Medicine
Volume 110, Issue 7 , Pages 543-550, May 2001

A case-management program of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: the Heartcare I Trial☆

  • Alain Nordmann, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • Equally contributed to this article.
    • ,
  • Iris Heilmbauer, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • ,
  • Tobias Walker, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • ,
  • Benedict Martina, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • ,
  • Edouard Battegay, MD

      Affiliations

    • Medical Outpatient Division, Department of Internal Medicine, University Hospital, Basel, Switzerland
    • Corresponding Author InformationRequests for reprints should be addressed to Edouard Battegay, MD, Medical Outpatient Division, Department of Internal Medicine, University Hospital, CH-4031 Basel, Switzerland

Received 16 October 2000; received in revised form 29 January 2001; accepted 29 January 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by a grant (96-8068) from the Swiss Federal Office of Health, a study grant (48602) from the University Hospital, Basel, Switzerland, and an unrestricted study grant from Merck, Sharp & Dohme, Switzerland. Dr. Battegay was a recipient of a SCORE grant (32-31948.91) of the Swiss National Science Foundation.

PII: S0002-9343(01)00682-9

The American Journal of Medicine
Volume 110, Issue 7 , Pages 543-550, May 2001

Article Tools